Reference Language for Use of Shared Resource
citation: “The Flow Cytometry Shared Resource services are supported by the Comprehensive Cancer Center
of Wake Forest Baptist Medical Center, NCI CCSG P30CA012197 grant.”
Program Key: CPC = Cancer Prevention and Control
Program; CRP = Clinical Research Program; TPR = Tumor Progression and
Recurrence Program; CBB = Cancer Biology and Biochemistry Program
- Wu K, Fukuda K, Xing F, Zhang Y, Sharma S, Liu Y,
Chan MD, Zhou X, Qasem SA, Pochampally R, Mo YY, Watabe K (TPR). Roles of the
cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metastasis of
breast cancer. J. Biol. Chem. 2015;290(15):9842-54. PMC4392281.
J, Mims J, Carroll DL, Akman SA (CRP), Furdui CM (CBB), Torti SV (CBB), Singh RN (CBB).
Differential cytotoxic and radiosensitizing effects of silver nanoparticles on
triple-negative breast cancer and non-triple-negative breast cells. Int J
Nanomedicine. 2015. 10:3937-53. PMC4501353.
- Pardee T (CRP), Stadelman K, Jennings-Gee J, Caudell D (CRP), and Gmeiner W (CBB). The poison oligonucleotide F10 is highly effective
against acute lymphoblastic leukemia while sparing normal hematopoietic cells. Oncotarget. 2014; 5: 4170-4179.
Z, Mott RT, Fry EA, Taneja P, Kulik G (TPR),
Sui G (TPR), and Inoue K. Cooperation
between Dmp1 loss and cyclin D1 overexpression in breast cancer. Am J Pathol.
2013; 183:1339-1350. PMC3791682.
I, Stuart CH, Kulik G (TPR), Gmeiner WH (CBB). Dimeric DNA aptamer
complexes for high-capacity–targeted drug delivery using pH-sensitive covalent
linkages. Mol Ther-Nucl Acids. 2013;
S, Moore ML, Grayson JM (TPR), Dubey P (TPR). Increased CD8+ T-cell function
following castration and immunization is countered by parallel expansion of
regulatory T cells. Cancer Res. 2012; 72:1975-85. PMC3690568.
EM, Wilkinson AS, Jackson JS, Mehra R, Varambally S, Chinnaiyan AM, Wilkinson JC (TPR). The enzymatic activity of
apoptosis-inducing factor supports energy metabolism benefiting the growth and
invasiveness of advanced prostate cancer cells. J Biol Chem. 2012; 287:43862-43875.
- Pardee TS (CRP), Gomes E,
Caudell D (CRP), Gmeiner WH (CBB). Unique dual targeting of
thymidylate synthase and topoisomerase1 by FdUMP results in high efficacy
against AML and low toxicity. Blood. 2012;119:3561-70. PMC3325043.